Terpos E - Search Results

1

Hematological findings and complications of COVID-19.

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Terpos E, et al. Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23. Am J Hematol. 2020. PMID: 32282949 Free PMC article.

2

New insights into the pathophysiology and management of bone disease in multiple myeloma.

Terpos E, Politou M, Rahemtulla A. Terpos E, et al. Br J Haematol. 2003 Dec;123(5):758-69. doi: 10.1046/j.1365-2141.2003.04712.x. Br J Haematol. 2003. PMID: 14632767 Free article. Review. No abstract available.

3

Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration.

Terpos E, Politou M, Rahemtulla A. Terpos E, et al. J Cancer Res Clin Oncol. 2004 Oct;130(10):623-5. doi: 10.1007/s00432-004-0593-4. Epub 2004 Jul 28. J Cancer Res Clin Oncol. 2004. PMID: 15449188

4

The role of markers of bone remodeling in multiple myeloma.

Terpos E, Politou M, Rahemtulla A. Terpos E, et al. Blood Rev. 2005 May;19(3):125-42. doi: 10.1016/j.blre.2004.06.001. Blood Rev. 2005. PMID: 15748961 Review.

5

Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma.

Terpos E, Politou M, Viniou N, Rahemtulla A. Terpos E, et al. Leuk Lymphoma. 2005 Dec;46(12):1699-707. doi: 10.1080/10428190500175049. Leuk Lymphoma. 2005. PMID: 16263571 Review.

6

Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.

Dimopoulos MA, Anagnostopoulos A, Terpos E, Repoussis P, Zomas A, Katodritou E, Kyrtsonis MC, Delibasi S, Vassou A, Pouli A, Zervas K, Anagnostopoulos N, Maniatis A; Greek Myeloma Study Group. Dimopoulos MA, et al. Among authors: terpos e. Haematologica. 2006 Feb;91(2):252-4. Haematologica. 2006. PMID: 16461313 Clinical Trial.

7

Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) in Waldenström macroglobulinaemia.

Terpos E, Anagnostopoulos A, Kastritis E, Bamias A, Tsionos K, Dimopoulos MA. Terpos E, et al. Br J Haematol. 2006 May;133(3):301-4. doi: 10.1111/j.1365-2141.2006.06017.x. Br J Haematol. 2006. PMID: 16643432 Free article.

8

Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.

Politou MC, Heath DJ, Rahemtulla A, Szydlo R, Anagnostopoulos A, Dimopoulos MA, Croucher PI, Terpos E. Politou MC, et al. Among authors: terpos e. Int J Cancer. 2006 Oct 1;119(7):1728-31. doi: 10.1002/ijc.22033. Int J Cancer. 2006. PMID: 16646053 Free article.

9

Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.

Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D, Moulopoulos LA, Bamia C, Terpos E, Tsionos K, Bamias A. Dimopoulos MA, et al. Among authors: terpos e. Haematologica. 2006 Jul;91(7):968-71. Epub 2006 Jun 1. Haematologica. 2006. PMID: 16757414 Clinical Trial.

10

Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.

Kastritis E, Terpos E, Anagnostopoulos A, Xilouri I, Dimopoulos MA. Kastritis E, et al. Among authors: terpos e. Clin Lymphoma Myeloma. 2006 Jul;7(1):73-6. doi: 10.3816/CLM.2006.n.043. Clin Lymphoma Myeloma. 2006. PMID: 16879774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

704 results

Search Page